Cargando…
Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control
Infection with the human immunodeficiency virus (HIV), when left untreated, typically leads to disease progression towards acquired immunodeficiency syndrome. Some people living with HIV (PLWH) control their virus to levels below the limit of detection of standard viral load assays, without treatmen...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205404/ https://www.ncbi.nlm.nih.gov/pubmed/35720328 http://dx.doi.org/10.3389/fimmu.2022.879124 |
_version_ | 1784729122987048960 |
---|---|
author | Bernard, Nicole F. Kant, Sanket Kiani, Zahra Tremblay, Cécile Dupuy, Franck P. |
author_facet | Bernard, Nicole F. Kant, Sanket Kiani, Zahra Tremblay, Cécile Dupuy, Franck P. |
author_sort | Bernard, Nicole F. |
collection | PubMed |
description | Infection with the human immunodeficiency virus (HIV), when left untreated, typically leads to disease progression towards acquired immunodeficiency syndrome. Some people living with HIV (PLWH) control their virus to levels below the limit of detection of standard viral load assays, without treatment. As such, they represent examples of a functional HIV cure. These individuals, called Elite Controllers (ECs), are rare, making up <1% of PLWH. Genome wide association studies mapped genes in the major histocompatibility complex (MHC) class I region as important in HIV control. ECs have potent virus specific CD8(+) T cell responses often restricted by protective MHC class I antigens. Natural Killer (NK) cells are innate immune cells whose activation state depends on the integration of activating and inhibitory signals arising from cell surface receptors interacting with their ligands on neighboring cells. Inhibitory NK cell receptors also use a subset of MHC class I antigens as ligands. This interaction educates NK cells, priming them to respond to HIV infected cell with reduced MHC class I antigen expression levels. NK cells can also be activated through the crosslinking of the activating NK cell receptor, CD16, which binds the fragment crystallizable portion of immunoglobulin G. This mode of activation confers NK cells with specificity to HIV infected cells when the antigen binding portion of CD16 bound immunoglobulin G recognizes HIV Envelope on infected cells. Here, we review the role of NK cells in antibody independent and antibody dependent HIV control. |
format | Online Article Text |
id | pubmed-9205404 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92054042022-06-18 Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control Bernard, Nicole F. Kant, Sanket Kiani, Zahra Tremblay, Cécile Dupuy, Franck P. Front Immunol Immunology Infection with the human immunodeficiency virus (HIV), when left untreated, typically leads to disease progression towards acquired immunodeficiency syndrome. Some people living with HIV (PLWH) control their virus to levels below the limit of detection of standard viral load assays, without treatment. As such, they represent examples of a functional HIV cure. These individuals, called Elite Controllers (ECs), are rare, making up <1% of PLWH. Genome wide association studies mapped genes in the major histocompatibility complex (MHC) class I region as important in HIV control. ECs have potent virus specific CD8(+) T cell responses often restricted by protective MHC class I antigens. Natural Killer (NK) cells are innate immune cells whose activation state depends on the integration of activating and inhibitory signals arising from cell surface receptors interacting with their ligands on neighboring cells. Inhibitory NK cell receptors also use a subset of MHC class I antigens as ligands. This interaction educates NK cells, priming them to respond to HIV infected cell with reduced MHC class I antigen expression levels. NK cells can also be activated through the crosslinking of the activating NK cell receptor, CD16, which binds the fragment crystallizable portion of immunoglobulin G. This mode of activation confers NK cells with specificity to HIV infected cells when the antigen binding portion of CD16 bound immunoglobulin G recognizes HIV Envelope on infected cells. Here, we review the role of NK cells in antibody independent and antibody dependent HIV control. Frontiers Media S.A. 2022-05-20 /pmc/articles/PMC9205404/ /pubmed/35720328 http://dx.doi.org/10.3389/fimmu.2022.879124 Text en Copyright © 2022 Bernard, Kant, Kiani, Tremblay and Dupuy https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Bernard, Nicole F. Kant, Sanket Kiani, Zahra Tremblay, Cécile Dupuy, Franck P. Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control |
title | Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control |
title_full | Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control |
title_fullStr | Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control |
title_full_unstemmed | Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control |
title_short | Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control |
title_sort | natural killer cells in antibody independent and antibody dependent hiv control |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205404/ https://www.ncbi.nlm.nih.gov/pubmed/35720328 http://dx.doi.org/10.3389/fimmu.2022.879124 |
work_keys_str_mv | AT bernardnicolef naturalkillercellsinantibodyindependentandantibodydependenthivcontrol AT kantsanket naturalkillercellsinantibodyindependentandantibodydependenthivcontrol AT kianizahra naturalkillercellsinantibodyindependentandantibodydependenthivcontrol AT tremblaycecile naturalkillercellsinantibodyindependentandantibodydependenthivcontrol AT dupuyfranckp naturalkillercellsinantibodyindependentandantibodydependenthivcontrol |